The International Affairs Committee endeavors to advance molecular pathology around the globe through educational and professional activities. It was established in 2010 as a working group, became an ad hoc committee in 2015 and became a standing committee in 2019.
Although the majority of AMP members reside in the U.S., the AMP founding members desired to create a global organization. Today, AMP International Affairs Committee members and International Affiliates can be found in more than 50 countries and all continents except Antarctica.
If you are interested in serving on the International Affairs Committee, please see the various roles available and the responsibilities of each role by clicking here.
%20(1).png)
This reference card was prepared by the AMP International Affairs Committee and sponsored by the AMP Training and Education Committee. The primary authors were Roberta Sitnik and Brittany Coffman.
For patients with DPYD gene variants, standard dosing of fluoropyrimidine drugs can lead to severe and sometimes life-threatening toxicity. DPYD testing can advance safe, personalized cancer treatment across diverse healthcare settings. This webinar features speaker Sony Tuteja of the Penn Medicine Center for Genomic Medicine.
Chair
Rami Mahfouz, M.D.
American University of Beirut Medical Center
Kenneth Chang, MBCHB
KK Women's & Children's Hospital
Renata Coudry, M.D., Ph.D.
Hospital Sirio Libanes
Francesco Curcio, M.D.
University of Udine
Jieun Kim, M.D., Ph.D.
Soonchunhyang University Seoul Hospital
Fernando Lopez–Rios, M.D.
Hospital Universitario 12 de Octubre- Madrid
Deepak Mishra, M.D.
Tata Medical Centre
Federico A. Monzon, M.D.
Genomic Path
Nikhil Patkar, M.D.
Tata Memorial Centre
Nicole Pfarr
Institute of Pathology Technical University Munich
Laveniya Satgunaseelan, MBBS
Royal Prince Alfred Hospital
Roberta Sitnik, Ph.D.
Hospital Israelita Albert Einstein
Advisers
Helen Fernandes, Ph.D.
Columbia University
Jin-Yeong Han, M.D., Ph.D.
Dong-A University, College of Medicine
President
Aaron D. Bossler, M.D., Ph.D.
Moffitt Cancer Research Center
Chief Executive Officer
Lauren S. Menser, CAE